Hambleton Julie
Insider CIK 1578771 · FPRX SVP & Chief Medical Officer · IGMS Director · IDYA SVP, Chief Medical Officer · ERAS Director · SWTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERAS Erasca, Inc. | A Award deriv | 2026-06-26 | 2026-06-29 | 29,888 | — | $0 | 29,888 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer | 2025-08-14 | 2025-08-14 | 2,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 14,668 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 14,155 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 14,155 | SEC↗ |
| SWTX SpringWorks Therapeutics, | M Exercise deriv | 2025-02-10 | 2025-02-12 | 13,774 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | M Exercise | 2025-02-10 | 2025-02-12 | 13,774 | $32.27 | $444.5K | 17,869 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-10 | 2025-02-12 | 13,774 | $53.01 | $730.2K | 4,095 | SEC↗ |
| IGMS IGM Biosciences, Inc. | M Exercise deriv | 2024-07-25 | 2024-07-29 | 15,132 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | M Exercise | 2024-07-25 | 2024-07-29 | 15,132 | $1.39 | $21.0K | 17,132 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2024-07-25 | 2024-07-29 | 15,132 | $14.00 | $211.8K | 2,000 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 2,946 | $39.41 | $116.1K | 5,797 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 751 | $40.57 | $30.5K | 5,046 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 20 | $42.09 | $842 | 4,095 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 931 | $41.49 | $38.6K | 4,115 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 8,743 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 29,400 | — | $0 | 29,400 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2023-07-19 | 2023-07-21 | 2,418 | $29.31 | $70.9K | 4,648 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2023-06-20 | 2023-06-22 | 2,400 | $26.92 | $64.6K | 7,066 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 9,466 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 15,500 | — | $0 | 15,500 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2023-03-15 | 2023-03-16 | 1,106 | $31.50 | $34.8K | 4,818 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-05-19 | 2022-05-20 | 15,318 | — | $0 | 15,318 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-05-19 | 2022-05-20 | 4,818 | — | $0 | 5,924 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2022-03-12 | 2022-03-15 | 29,497 | — | $0 | 29,497 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2021-08-09 | 2021-08-11 | 1,000 | $80.00 | $80.0K | 2,000 | SEC↗ |
| ERAS Erasca, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 6,000 | $16.00 | $96.0K | 6,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2021-06-01 | 2021-06-03 | 2,000 | $80.00 | $160.0K | 3,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-05-20 | 2021-05-21 | 6,998 | — | $0 | 6,998 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-05-20 | 2021-05-21 | 1,106 | — | $0 | 5,995 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2021-02-19 | 2021-02-23 | 6,423 | — | $0 | 6,423 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-05-20 | 2020-05-22 | 14,668 | — | $0 | 14,668 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2020-02-21 | 2020-02-25 | 62,500 | — | $0 | 62,500 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2020-02-05 | 2020-02-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2019-09-18 | 2019-09-20 | 5,000 | $18.31 | $91.5K | 5,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2019-09-17 | 2019-09-19 | 12,100 | — | $0 | 12,100 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-11-11 | 2015-11-13 | 12,000 | — | $0 | 38,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2015-11-11 | 2015-11-13 | 10,000 | — | $0 | 14,390 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2015-11-11 | 2015-11-13 | 3,400 | $35.23 | $119.8K | 85,919 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-11-11 | 2015-11-13 | 10,000 | $7.26 | $72.6K | 95,919 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2015-11-11 | 2015-11-13 | 12,000 | $34.33 | $412.0K | 85,919 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2015-11-11 | 2015-11-13 | 12,000 | $11.14 | $133.7K | 97,919 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2015-11-11 | 2015-11-13 | 1,108 | $35.33 | $39.1K | 84,811 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2015-11-11 | 2015-11-13 | 6,600 | $34.75 | $229.3K | 89,319 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-08-20 | 2015-08-21 | 75,000 | — | $0 | 85,740 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-08-17 | 2015-08-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-04-30 | 2015-05-04 | 7,980 | — | $0 | 9,979 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2014-08-22 | 2015-10-30 | 400 | $10.75 | $4.3K | 1,700 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-08-22 | 2014-08-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2013-11-06 | 2015-10-30 | 500 | $10.10 | $5.0K | 1,300 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2013-09-30 | 2015-10-30 | 64 | $13.70 | $877 | 64 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | P Buy | 2013-09-18 | 2015-10-30 | 800 | $14.75 | $11.8K | 800 | SEC↗ |